Im Cannabis(NASDAQ) IMCC

IM Cannabis Corp. specializes in the cultivation, production, and provision of medicinal cannabis goods across international markets, including Israel, Germany, and Canada. The company offers a diverse range of cannabis products, including flowers and extracts, marketed under its IMC brand, as well as dried flower and pre-rolled products through its WAGNERS and Highland Grow labels.

Products and Services

• Medicinal cannabis products for medical patients
• Recreational cannabis offerings for adult consumers
• Variety of cannabis formats, including flowers and extracts

Growth Outlook

• Expansion into new international markets is underway
• Increasing demand for medicinal cannabis products is evident
• Strategic partnerships are being formed to enhance distribution

Financial Highlights

• Q2 2026 revenue of 7.79 million CAD, showing market presence
• Trailing twelve months (TTM) gross profit margin at 27.3%
• Operating cash flow per share of 1.22 CAD indicates operational efficiency

IM Cannabis Corp. is positioned in a growing industry, with a focus on both medicinal and recreational cannabis markets. The company's diverse product offerings cater to a wide range of consumers, enhancing its market reach. Recent financial data indicates a revenue of 7.79 million CAD for Q2 2026, reflecting the company's ability to generate income despite challenges. The TTM gross profit margin of 27.3% suggests effective cost management and product pricing strategies. Additionally, the operating cash flow per share of 1.22 CAD highlights the company's operational efficiency, which is crucial for sustaining growth and navigating the competitive landscape. As the demand for cannabis products continues to rise, IM Cannabis Corp. is strategically positioned to capitalize on emerging opportunities in the global market.